Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | POLB | P06746 | 1/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | CNOT7 | Q9UIV1 | 4/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | CASR | P41180 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | COMT | P21964 | 1/20 | 0.39 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7984403 | 0.94 | CNOT7 (0.47) | LMNAKDM4EPOLBMAPK1CNOT7 | |
| SCHEMBL7984240 | 0.90 | LMNA (0.58) | LMNAKDM4EPOLBMAPK1CNOT7 | |
| SCHEMBL7987627 | 0.88 | KDM4E (0.50) | LMNAKDM4EPOLBMAPK1CNOT7 | |
| SCHEMBL7986351 | 0.88 | KDM4E (0.50) | LMNAKDM4EPOLBMAPK1CNOT7 | |
| SCHEMBL7974290 | 0.88 | KDM4E (0.50) | LMNAKDM4EPOLBMAPK1CNOT7 | |
| SCHEMBL7985332 | 0.88 | SMN1; SMN2 (0.55) | CNOT7ALDH1A1SMN1; SMN2HPGDKMT2A | |
| SCHEMBL7984893 | 0.85 | KDM4E (0.50) | LMNAKDM4EPOLBMAPK1CNOT7 | |
| SCHEMBL7992307 | 0.84 | CNOT7 (0.54) | LMNAKDM4EPOLBMAPK1CNOT7 | |
| SCHEMBL7991648 | 0.83 | KDM4E (0.54) | LMNAKDM4EPOLBMAPK1CNOT7 | |
| SCHEMBL7974041 | 0.83 | KDM4E (0.51) | LMNAKDM4EPOLBMAPK1CNOT7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6310070-B1 | FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS | JAPAN ENERGY CORPORATION (JP) | 2001-10-30 | — | — | US | disclosed |
| EP-0999211-A1 | NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF | JAPAN ENERGY CORPORATION (JP) | 2000-05-10 | — | — | EP | disclosed |